Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values

INTRODUCTION: Batch differences in cerebrospinal fluid (CSF) biomarker measurement can introduce bias into analyses for Alzheimer's disease studies. We evaluated and adjusted for batch differences using statistical methods. METHODS: A total of 792 CSF samples from 528 participants were assayed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yue, Norton, Derek L., Van Hulle, Carol A., Chappell, Richard J., Lazar, Karen K., Jonaitis, Erin M., Koscik, Rebecca L., Clark, Lindsay R., Krause, Rachel, Andreasson, Ulf, Chin, Nathaniel A., Bendlin, Barbara B., Asthana, Sanjay, Okonkwo, Ozioma C., Gleason, Carey E., Johnson, Sterling C., Zetterberg, Henrik, Blennow, Kaj, Carlsson, Cynthia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cerebrospinal Fluid Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144935/
https://www.ncbi.nlm.nih.gov/pubmed/34084888
http://dx.doi.org/10.1002/dad2.12194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144935/
https://www.ncbi.nlm.nih.gov/pubmed/34084888
http://dx.doi.org/10.1002/dad2.12194

Ejemplares similares